Search

everythinglearnresearchcommunity

for

Search:↓

A patient with sickle cell trait and low vitamin D might have lupus, a rare combination that needs more attention.

Active treatment can help prevent scarring hair loss in SLE patients.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Skin symptoms in lupus help diagnose and manage the disease early.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Managing multiple autoimmune diseases in one patient is very challenging.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Systemic lupus erythematosus is a complex autoimmune disease mainly affecting women, with varied symptoms and unknown exact cause.

Systemic lupus erythematosus is an autoimmune disease causing diverse symptoms and major organ involvement.

Discoid Lupus Erythematosus is more common in women aged 31-40, often worsened by sunlight, and confirmed by specific lab tests.

Neonatal lupus symptoms usually resolve, but some children may develop other autoimmune diseases later.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.